Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Blue Sky Biotech, Inc.

Blue Sky Biotech, Inc. has completed a recapitalization with Boston-based private equity firm Ampersand Ventures.  Blue Sky Biotech, Inc., based in Massachusetts, is a Contract Research Organization (CRO). The financial terms of the deal were not disclosed.  Provident Healthcare Partners acted as exclusive financial advisor to Blue Sky Biotech, Inc.